Personalized Nutrition Market - 2022-2031

March 2025 | 210 pages | ID: P89145A51379EN
DataM Intelligence

Abstracts

The Personalized Nutrition Market was valued at USD 17.4 billion in 2022 and is anticipated to reach USD 48.9 billion by 2031, at a CAGR of 0.138 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Personalized Nutrition Market.

This report delivers a comprehensive overview of the Personalized Nutrition Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Personalized Nutrition Market. The Personalized Nutrition Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.

Personalized Nutrition Market Scope:

By Type

• Active Measurement
• Standard Measurement

By Dosage Form

• Tablets
• Capsules
• Powders
• Liquids

By Distribution Channel

• Supermarkets/Hypermarkets
• Specialty Stores
• Retail Pharmacies
• E-Commerce
• Others

By Application

• Standard Supplements
• Disease Based Supplements

By End-User

• Over the Counter (OTC)
• Wellness and Fitness Centers
• Hospitals and Clinics
• Others

Key Players

• NutraGene
• Nestle Health Science
• Nutrigenomix Inc.
• Nutrafol Inc.
• DNAfit Ltd.
• Symrise
• GenoPalate Inc.
• 23andMe Inc.
• Viome Inc.
• BASF SE

Major Highlights

This report delivers a comprehensive overview of the Personalized Nutrition Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Personalized Nutrition Market. The Personalized Nutrition Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet By Type
3.2. Snippet By Dosage Form
3.3. Snippet By Distribution Channel
3.4. Snippet By Application
3.5. Snippet By End-User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Product Innovations
    4.1.1.2. Advancements in Genetic and Health Data Analysis
  4.1.2. Restraints
    4.1.2.1. Cost and Accessibility
    4.1.2.2. Lack of Standardization and Oversight
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID
  6.1.2. Scenario During COVID
  6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. Active Measurement*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Apps
  7.2.4. Testing Kits
  7.2.5. Programs
7.3. Standard Measurement

8. BY DOSAGE FORM

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  8.1.2. Market Attractiveness Index, By Dosage Form
8.2. Tablets*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Powders
8.5. Liquids

9. BY DISTRIBUTION CHANNEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Supermarkets/Hypermarkets*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Stores
9.4. Retail Pharmacies
9.5. E-Commerce
9.6. Others

10. BY APPLICATION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.1.2. Market Attractiveness Index, By Application
10.2. Standard Supplements*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  10.2.3. Health Nutrition
  10.2.4. Sports Nutrition
10.3. Disease Based Supplements
  10.3.1. Lifestyle
  10.3.2. Inherited

11. BY END-USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.1.2. Market Attractiveness Index, By End-User
11.2. Over the Counter (OTC)*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Wellness and Fitness Centers
11.4. Hospitals and Clinics
11.5. Others

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.8.1. U.S.
    12.2.8.2. Canada
    12.2.8.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.8.1. Germany
    12.3.8.2. UK
    12.3.8.3. France
    12.3.8.4. Italy
    12.3.8.5. Russia
    12.3.8.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. Brazil
    12.4.8.2. Argentina
    12.4.8.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. China
    12.5.8.2. India
    12.5.8.3. Japan
    12.5.8.4. Australia
    12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. NutraGene
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Financial Overview
  14.1.4. Key Developments
14.2. Nestl? Health Science
14.3. Nutrigenomix Inc.
14.4. Nutrafol Inc.
14.5. DNAfit Ltd.
14.6. Symrise
14.7. GenoPalate Inc.
14.8. 23andMe Inc.
14.9. Viome Inc.
14.10. BASF SE (LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us